Literature DB >> 16864181

Could the hand-foot syndrome after capecitabine treatment be associated with better outcome in metastatic breast cancer patients?

Mevlut Kurt, Sercan Aksoy, Nilufer Guler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864181     DOI: 10.1080/02841860600791509

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  4 in total

1.  Conjecture about Hand-Foot Syndrome in CLASSIC Trial.

Authors:  Guo-Sheng Wang
Journal:  Iran J Public Health       Date:  2014-04       Impact factor: 1.429

2.  Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer.

Authors:  Shaoyan Lin; Jian Yue; Xiuwen Guan; Peng Yuan; Jiayu Wang; Yang Luo; Ying Fan; Ruigang Cai; Qiao Li; Shanshan Chen; Pin Zhang; Qing Li; Fei Ma; Binghe Xu
Journal:  Cancer Commun (Lond)       Date:  2019-10-11

3.  Clinical management of localized colon cancer with capecitabine.

Authors:  J Quidde; D Arnold; A Stein
Journal:  Clin Med Insights Oncol       Date:  2012-11-05

4.  Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.

Authors:  Christoph Zielinski; Istvan Lang; Semir Beslija; Zsuzsanna Kahan; Moshe J Inbar; Salomon M Stemmer; Rodica Anghel; Damir Vrbanec; Diethelm Messinger; Thomas Brodowicz
Journal:  Br J Cancer       Date:  2015-12-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.